The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

lgp by the numbers
More From The Market Online

Pacific Edge’s APAC operations advancing towards profit with cancer test growth

Pacific Edge APAC business is advancing towards profitability on a direct-cost basis with a growing interest…
The Market Online Video

Syntara shows encouraging first signals it can impact the path to Parkinson’s

Syntara (ASX:SNT) has reported encouraging interim results from its Phase 2 study of SNT-4728, providing the first clinical evidence
Diabetes concept

Entropy reports 50% remission in Phase 2 psychedelic trial for binge eating disorder

Entropy Neurodynamics says its Phase 2 trial of TRP-8803 delivered 50% remission in all treatment-resistant binge…

Syntara reports encouraging early Parkinson’s trial results

Syntara has reported statistically significant reductions in brain inflammation in an early-stage Parkinson's disease study.